Reuters logo
in 17 days
BRIEF-Auris Medical completes enrollment of phase 3 healos trial of am-111 for the treatment of sudden deafness
July 5, 2017 / 12:30 PM / in 17 days

BRIEF-Auris Medical completes enrollment of phase 3 healos trial of am-111 for the treatment of sudden deafness

1 Min Read

July 5 (Reuters) - Auris Medical Holding AG:

* Auris Medical completes enrollment of phase 3 healos trial of am-111 for the treatment of sudden deafness

* Auris Medical Holding AG - ‍top-line results from healos trial are expected in fall of 2017.​

* Says ‍auris Medical expects to announce top-line results from assent trial in second half of 2018​

* Auris Medical Holding AG - ‍primary efficacy endpoint for trial is improvement of pure tone hearing thresholds from baseline to day 28​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below